(PDF) Conditioning Prior to CAR T Cells Predicts Response

Conditioning Prior to CAR T Cells Predicts Response and Survival in Pediatric/Young Adult Relapse/Refractory (R/R) B-All

Biology of Blood and Marrow Transplantation - Netherlands

doi 10.1016/j.bbmt.2018.12.309

Full Text

Open PDF

Abstract

Available in full text

Date

March 1, 2019

Authors

Andromachi Scaradavou

Publisher

Elsevier BV

Related search

Chimeric Antigen Receptor T-Cells (Car-T) for Refractory and Relapsed Burkitt's Lymphoma: Early Response in Pediatric Patients

Hematological Oncology

English

A Phase I Trial of 19-28z Car-T Cells Post-High Dose Therapy and Autologous Transplantation (Hdt-Asct) for Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)

Hematological Oncology

English

Role of Remission Status and Prior Transplant in Optimizing Survival Outcomes Following Allogeneic Hematopoietic Stem Transplantation (HSCT) in Patients Who Received Inotuzumab Ozogamicin for Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

Spectral Order a ≻ B if and Only if A^(2p-R) ≥ ( A^(-R / 2) B^p A^(-R / 2) )^( (2p-R) / (P-R) ) for All P > R ≥ 0 and Its Application

Mathematical Inequalities and Applications

Mathematics

Applied Mathematics

2001

English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B- And T-Cell Lymphoma

Hematological Oncology

English

Real-World Bendamustine Use in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R Dlbcl)

Hematological Oncology

English

Novel BAFF-R CAR T-Cell Therapy for CD19 Antigen-Loss Relapsed B Cell Tumors

Hematological Oncology

English

Oral Azacytidine (Aza) and Romidepsin (R) Reveals Promising Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)

Hematological Oncology

English

$$\Kappa (R,T)$$κ(R,T) Gravity

European Physical Journal C

English

Amanote Research

Conditioning Prior to CAR T Cells Predicts Response and Survival in Pediatric/Young Adult Relapse/Refractory (R/R) B-All

Biology of Blood and Marrow Transplantation - Netherlands

doi 10.1016/j.bbmt.2018.12.309

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Chimeric Antigen Receptor T-Cells (Car-T) for Refractory and Relapsed Burkitt's Lymphoma: Early Response in Pediatric Patients

A Phase I Trial of 19-28z Car-T Cells Post-High Dose Therapy and Autologous Transplantation (Hdt-Asct) for Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)

Role of Remission Status and Prior Transplant in Optimizing Survival Outcomes Following Allogeneic Hematopoietic Stem Transplantation (HSCT) in Patients Who Received Inotuzumab Ozogamicin for Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Spectral Order a ≻ B if and Only if A^(2p-R) ≥ ( A^(-R / 2) B^p A^(-R / 2) )^( (2p-R) / (P-R) ) for All P > R ≥ 0 and Its Application

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B- And T-Cell Lymphoma

Real-World Bendamustine Use in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R Dlbcl)

Novel BAFF-R CAR T-Cell Therapy for CD19 Antigen-Loss Relapsed B Cell Tumors

Oral Azacytidine (Aza) and Romidepsin (R) Reveals Promising Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)

$$\Kappa (R,T)$$κ(R,T) Gravity